File Download
  Patent History
  • Application
    US 11/313513 2005-12-21
  • Publication
    US 20070298127 2007-12-27
  • Granted
    US 7468434 2008-12-23
Supplementary

granted patent: Diazene-Bridge Crown Ether Lithium Compounds And Methods For Their Use

TitleDiazene-Bridge Crown Ether Lithium Compounds And Methods For Their Use
Granted PatentUS 7468434
Granted Date2008-12-23
Priority Date2005-12-21 US 11/313513
2004-12-22 US 11/638100P
Inventors
Issue Date2008
Citation
US Patent 7468434. Washington, DC: US Patent and Trademark Office (USPTO), 2008 How to Cite?
Abstract
This Invention Provides A Method For Treating An Eye Disease In A Patient Comprising: Providing A Photosensitive Prodrug That Releases Upon Exposure To Light An Active Ingredient To Treat The Eye Disease; Administering The Prodrug In A Pharmaceutically Accepted Vehicle To The Subject, And Exposing The Eye Of The Subject To An External Light Source To Cause The Prodrug To Release The Active Ingredient. This Invention Also Provides A Composition For The Treatment Of Glaucoma, Comprising A Compound Containing A Lithium Ion-Chelated In A Crown Ether- Or Aza-Crown Ether-Containing Chromene Or Diazene Derivative And A Pharmaceutically Acceptable Carrier.
Persistent Identifierhttp://hdl.handle.net/10722/142068

 

DC FieldValueLanguage
dc.date.accessioned2011-10-19T06:25:03Z-
dc.date.available2011-10-19T06:25:03Z-
dc.date.issued2008-
dc.identifier.citationUS Patent 7468434. Washington, DC: US Patent and Trademark Office (USPTO), 2008en_HK
dc.identifier.urihttp://hdl.handle.net/10722/142068-
dc.description.abstractThis Invention Provides A Method For Treating An Eye Disease In A Patient Comprising: Providing A Photosensitive Prodrug That Releases Upon Exposure To Light An Active Ingredient To Treat The Eye Disease; Administering The Prodrug In A Pharmaceutically Accepted Vehicle To The Subject, And Exposing The Eye Of The Subject To An External Light Source To Cause The Prodrug To Release The Active Ingredient. This Invention Also Provides A Composition For The Treatment Of Glaucoma, Comprising A Compound Containing A Lithium Ion-Chelated In A Crown Ether- Or Aza-Crown Ether-Containing Chromene Or Diazene Derivative And A Pharmaceutically Acceptable Carrier.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documents-
dc.titleDiazene-Bridge Crown Ether Lithium Compounds And Methods For Their Useen_HK
dc.typePatenten_US
dc.identifier.emailChe, Chi Ming:cmche@hku.hken_US
dc.identifier.emailSham, Hiu Tung Iona:en_US
dc.identifier.emailSo, Kwok Fai:en_US
dc.identifier.emailVanhoutte, Paul Michel Geo:vanhoutt@hkucc.hku.hken_US
dc.identifier.authorityChe, Chi Ming=rp00670en_US
dc.description.naturepublished_or_final_version-
dc.contributor.inventorVanhoutte, Paul Michel Geoen_US
dc.contributor.inventorChe, Chi Mingen_US
dc.contributor.inventorSo, Kwok Faien_US
dc.contributor.inventorSham, Hiu Tung Ionaen_US
patents.identifier.applicationUS 11/313513en_HK
patents.identifier.grantedUS 7468434en_HK
patents.description.assigneeUniv Hong Kong [Cn]en_HK
patents.description.countryUnited States of Americaen_HK
patents.date.publication2007-12-27en_HK
patents.date.granted2008-12-23en_HK
patents.identifier.hkutechidChm-2004-00168en_US
patents.date.application2005-12-21en_HK
patents.date.priority2005-12-21 US 11/313513en_HK
patents.date.priority2004-12-22 US 11/638100Pen_HK
patents.description.ccUSen_HK
patents.identifier.publicationUS 20070298127en_HK
patents.relation.familyCN 101115489 (A) 2008-01-30en_HK
patents.relation.familyDE 112005003183 (T5) 2007-11-08en_HK
patents.relation.familyGB 2437456 (A) 2007-10-24en_HK
patents.relation.familyJP 2008524268 (A) 2008-07-10en_HK
patents.relation.familyUS 2007298127 (A1) 2007-12-27en_HK
patents.relation.familyUS 7468434 (B2) 2008-12-23en_HK
patents.relation.familyWO 2006066511 (A1) 2006-06-29en_HK
patents.description.kindB2en_HK
patents.typePatent_granteden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats